LABD vs SCHD

ALABD

BSCHD

Measures won1–5SCHD wins · of 6 · 5Y

$10,000 · 5Y$16,638VIG · SCHD $16,459

Lowest cost0.04%VIG · $4 on $10k

Most income6.99%LABD · $699 on $10k

Smallest drop−6.9%SCHD · worst fall in 1Y

Held in common[…]LABD and SCHD

LABD

SCHD

Direxion Daily S&P Biotech Bear 3X ETF · $86MSchwab U.S. Dividend Equity ETF · $120B

−68.9%3 years · per year$301 · $17,123+19.6%

−47.4%5 years · per year$402 · $16,459+10.5%

1.08%Expense ratio$108 · $6 on $10k · lower wins0.06%

6.99%12-mo yield$699 · $296 on $10k2.96%

−80.6%Worst dropSmaller wins−6.9%

91.0%VolatilityLower wins11.8%

1–5SCHD wins

$10,000 · 5 yearsAll four, one scale

Shared top holdingsLABD · SCHD

They share no top holdings, or holdings aren’t on file […]

Held in common[…]

End-of-day Nov 9, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

All Four

5Y4 funds

#
1	VIG	Vanguard Dividend Appreciation ETFRead Desk	0.04%	1.46%	+2.4%	+14.8%	+17.6%	+18.8%	+10.7%	−7.9%	$109.1B
2	BSCHD	Schwab U.S. Dividend Equity ETFRead Desk	0.06%	2.96%	+1.4%	+33.2%	+39.1%	+19.6%	+10.5%	−6.9%	$119.9B
3	ALABD	Direxion Daily S&P Biotech Bear 3X ETFRead Desk	1.08%	6.99%	−9.1%	−68.1%	−77.8%	−68.9%	−47.4%	−80.6%	$86M
4	CGDV	Capital Group Dividend Value ETFRead Desk	0.33%	1.24%	+2.3%	+12.1%	+16.1%	+23.7%	new	−9.7%	$37.8B

End-of-day Nov 9, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

All Four

5Y4 funds

#
1	VIG	Vanguard Dividend Appreciation ETFRead Desk	0.04%	1.46%	+2.4%	+14.8%	+17.6%	+18.8%	+10.7%	−7.9%	$109.1B
2	BSCHD	Schwab U.S. Dividend Equity ETFRead Desk	0.06%	2.96%	+1.4%	+33.2%	+39.1%	+19.6%	+10.5%	−6.9%	$119.9B
3	ALABD	Direxion Daily S&P Biotech Bear 3X ETFRead Desk	1.08%	6.99%	−9.1%	−68.1%	−77.8%	−68.9%	−47.4%	−80.6%	$86M
4	CGDV	Capital Group Dividend Value ETFRead Desk	0.33%	1.24%	+2.3%	+12.1%	+16.1%	+23.7%	new	−9.7%	$37.8B

End-of-day Nov 9, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

LABD vs SCHD

LABD

Direxion Daily S&P Biotech Bear 3X

$402

SCHD

Schwab U.S. Dividend Equity

$16,459

MeasureLABDSCHD

Fee1.08%0.06%

Cost on $10k a year$108$6

Yield6.99%2.96%

5 years, per year−47.4%+10.5%

3 years, per year−68.9%+19.6%

Worst drop · 1Y−80.6%−6.9%

Volatility · 1Y91.0%11.8%

5–1measures won
SCHD first

Nov 9, 2026 · $10,000 five years ago, dividends reinvested

DGRO vs VIG

YTD

iSharesDGRO

+18.8%

VIGVanguard

+14.8%

+18.8%Year to date+14.8%

1.8%Yield1.5%

$44.7BAssets$109B

2–0DGRO wins

End-of-day Nov 9, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+6.6%

JEPIJ.P. Morgan

+7.5%

+6.6%Year to date+7.5%

12.4%Yield7.9%

$40.7BAssets$45.2B

1–1level

End-of-day Nov 9, 2026

SPYM vs SPY

YTD

SPDRSPYM

+11.3%

SPYSPDR

+11.2%

+11.3%Year to date+11.2%

1.0%Yield1.0%

$179BAssets$778B

1–0SPYM wins

End-of-day Nov 9, 2026

Overlap: LABD, VIG, CGDV, SCHD

Today

29.4%most shared, VIG and CGDV

LABDVIGCGDVSCHD

LABD—[…][…][…]

VIG[…]—29.4%14.5%

CGDV[…]29.4%—5.8%

SCHD[…]14.5%5.8%—

End-of-day Nov 9, 2026 · share held in common · outlined: the pair in versus

Income After Fees on $10,000

$591most kept, LABD

LABD$699 − $108 = $591

SCHD$296 − $6 = $290

VIG$146 − $4 = $142

CGDV$124 − $33 = $91

KeptFee

End-of-day Nov 9, 2026 · yield in dollars minus the fee